What drove CVS's revenue growth in Q4 2024?

CVS's revenue growth in Q4 2024 was driven by several key factors: 1. **Growth in Health Care Benefits and Pharmacy & Consumer Wellness Segments**: The Health Care Benefits segment saw a significant increase of over 25% in revenue, reaching approximately $32.99 billion. This growth was primarily driven by the expansion of the Health Care Benefits segment, which now includes approximately 27.1 million medical members. The Pharmacy & Consumer Wellness segment also contributed to the revenue growth, with revenues increasing by over 12% year-over-year to approximately $32.42 billion. 2. **Increase in Prescription Volume**: The growth in the Pharmacy & Consumer Wellness segment was primarily driven by increased prescription volume, including improved contributions from vaccinations and pharmacy drug mix. This indicates a strong demand for CVS's pharmacy services and the effectiveness of its marketing strategies. 3. **Same-Store Pharmacy Sales**: Same-store pharmacy sales increased nearly 20% year-over-year, reflecting strong customer engagement and retention in the CVS's pharmacy business. This suggests that CVS's focus on providing high-quality pharmacy services and its extensive store network are key drivers of its revenue growth. In summary, CVS's revenue growth in Q4 2024 was primarily driven by the growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments, which was fueled by increased prescription volume and same-store pharmacy sales.